Effect of Age and Weight Loss on Inflammation and Iron Homeostasis (HEP)
Primary Purpose
Obesity, Aging
Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Calorie Restriction
Sponsored by

About this trial
This is an interventional basic science trial for Obesity
Eligibility Criteria
Inclusion Criteria:
- Enrolling patients in the Weight and Wellness Center (WWC) at Tufts Medical Center, part of their Tufts Employees, low calorie diet (LCD) or pre-surgical low calorie diet (PS-LCD) program, or enrolling at WWC as individual patients.
- BMI in the range of 30 to 55 kg/m2.
- Either ages 18-45 or >60.
Exclusion Criteria:
- Pregnancy.
- Weight reduction greater than or equal to 3% in the past 3 months.
- Prior gastric restrictive surgery.
- Weight loss medications within the 4 weeks prior to screening.
- History of eating disorder.
- Renal disease (serum creatinine >2mg/dl).
- Hepatic disease, except for nonalcoholic steatohepatitis (NASH).
- Celiac disease, or any kind of intestinal malabsorption disorders.
- Gastrointestinal cancer.
- Hereditary hemochromatosis, or any blood disorders.
- Chronic infectious or inflammatory disease.
- Use of immunosuppressants.
- Severe iron deficiency anemia (hemoglobin<8 g/dl) or other conditions that would prevent them from discontinuing iron supplement use.
- Unwilling to discontinue iron supplement intake. The dietary plan recommended by the WWC will include daily intake of iron that meets the iron RDA for the subject's gender and age group, therefore discontinuing iron supplement will not be harmful for the participants. Intake of other supplements will not be an exclusion criteria, as long as it stays constant throughout the study period.
Sites / Locations
- JM USDA Human Nutrition Research Center on Aging
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Experimental
Arm Label
Young (18-45 years)
Older (>60 years)
Arm Description
Obese young women (18-45y) undergoing calorie restriction.
Obese older women (>60y) undergoing calorie restriction.
Outcomes
Primary Outcome Measures
Change in serum hepcidin
The investigators will determine the change in hepcidin at baseline and after 12-16 weeks of calorie restriction.
Change in inflammation (CRP, IL-6)
The investigators will determine the change in inflammation at baseline and after 12-16 weeks of calorie restriction.
Change in iron status
The investigators will determine the change in iron status at baseline and after 12-16 weeks of calorie restriction.
Secondary Outcome Measures
Change in PBMC intracellular iron content
Change in PBMC Hepcidin expression
Change in PBMC ferroportin expression
Change in PBMC subpopulations and proliferation
After stimulation with ConA, PHA and anti-CD3/CD28
Full Information
1. Study Identification
Unique Protocol Identification Number
NCT01636635
Brief Title
Effect of Age and Weight Loss on Inflammation and Iron Homeostasis
Acronym
HEP
Official Title
Effect of Age and Weight Loss on Obesity-related Inflammation and Iron Homeostasis in Women
Study Type
Interventional
2. Study Status
Record Verification Date
November 2015
Overall Recruitment Status
Completed
Study Start Date
March 2011 (undefined)
Primary Completion Date
November 2013 (Actual)
Study Completion Date
November 2013 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Tufts University
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The purpose of this study is to evaluate the effect of aging and weight loss on iron status and immune response in obese women. Iron deficiency and immune impairment are two of the numerous complications of obesity. The central hypothesis is that obesity-induced inflammation causes lower iron status through decreased iron absorption and availability in young and older obese women. Furthermore, the investigators hypothesize that this can be corrected with weight loss in both young and older obese women.
Detailed Description
Obese individuals have chronic inflammation, higher risk of iron deficiency, and impaired immune response. These are conditions seen also with aging, but it is unknown to what extent they may be further impacted by obesity in the elderly. With this study the investigators aim to establish the mechanism by which weight loss may reduce inflammation and enhance iron status in young and older obese adults through the peptide hormone hepcidin, which regulates iron homeostasis. The investigators also aim to identify a possible link between iron homeostasis and immune response through hepcidin, which has been implicated in T cell mediated immunity. The investigators hypothesize that obesity-induced inflammation causes dysregulation of hepcidin expression leading to lower iron status through decreased iron absorption and availability in young and older adults. Furthermore, the investigators hypothesize that hepcidin dysregulation, and thus iron status can be mitigated with weight loss in both young and older obese adults. This hypothesis will be tested in obese young and older women undergoing weight loss through calorie restriction. Change in iron status, inflammation, and hepcidin will be determined before and after weight loss. Further, the impact of inflammatory environment of obesity on peripheral blood mononuclear cell hepcidin, ferroportin, intracellular iron, and T cell function in young and older adults will be determined. This study will address two important public health problems, i.e. obesity and iron deficiency and will be an important step toward the identification of strategies to enhance health of obese young and older adults.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Obesity, Aging
7. Study Design
Primary Purpose
Basic Science
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
44 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Young (18-45 years)
Arm Type
Active Comparator
Arm Description
Obese young women (18-45y) undergoing calorie restriction.
Arm Title
Older (>60 years)
Arm Type
Experimental
Arm Description
Obese older women (>60y) undergoing calorie restriction.
Intervention Type
Other
Intervention Name(s)
Calorie Restriction
Intervention Description
Intervention consists of a calorically restricted diet regime designed and administered at the Weight and Wellness Center at Tufts University
Primary Outcome Measure Information:
Title
Change in serum hepcidin
Description
The investigators will determine the change in hepcidin at baseline and after 12-16 weeks of calorie restriction.
Time Frame
Baseline and 12-16 weeks
Title
Change in inflammation (CRP, IL-6)
Description
The investigators will determine the change in inflammation at baseline and after 12-16 weeks of calorie restriction.
Time Frame
Baseline and 12-16 weeks
Title
Change in iron status
Description
The investigators will determine the change in iron status at baseline and after 12-16 weeks of calorie restriction.
Time Frame
Baseline and 12-16 weeks
Secondary Outcome Measure Information:
Title
Change in PBMC intracellular iron content
Time Frame
Baseline and 12-16 weeks
Title
Change in PBMC Hepcidin expression
Time Frame
Baseline and 12-16 weeks
Title
Change in PBMC ferroportin expression
Time Frame
Baseline and 12-16 weeks
Title
Change in PBMC subpopulations and proliferation
Description
After stimulation with ConA, PHA and anti-CD3/CD28
Time Frame
Baseline and 12-16 weeks
10. Eligibility
Sex
Female
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria:
Enrolling patients in the Weight and Wellness Center (WWC) at Tufts Medical Center, part of their Tufts Employees, low calorie diet (LCD) or pre-surgical low calorie diet (PS-LCD) program, or enrolling at WWC as individual patients.
BMI in the range of 30 to 55 kg/m2.
Either ages 18-45 or >60.
Exclusion Criteria:
Pregnancy.
Weight reduction greater than or equal to 3% in the past 3 months.
Prior gastric restrictive surgery.
Weight loss medications within the 4 weeks prior to screening.
History of eating disorder.
Renal disease (serum creatinine >2mg/dl).
Hepatic disease, except for nonalcoholic steatohepatitis (NASH).
Celiac disease, or any kind of intestinal malabsorption disorders.
Gastrointestinal cancer.
Hereditary hemochromatosis, or any blood disorders.
Chronic infectious or inflammatory disease.
Use of immunosuppressants.
Severe iron deficiency anemia (hemoglobin<8 g/dl) or other conditions that would prevent them from discontinuing iron supplement use.
Unwilling to discontinue iron supplement intake. The dietary plan recommended by the WWC will include daily intake of iron that meets the iron RDA for the subject's gender and age group, therefore discontinuing iron supplement will not be harmful for the participants. Intake of other supplements will not be an exclusion criteria, as long as it stays constant throughout the study period.
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Simin N Meydani, DVM, PhD
Organizational Affiliation
Tufts University
Official's Role
Principal Investigator
Facility Information:
Facility Name
JM USDA Human Nutrition Research Center on Aging
City
Boston
State/Province
Massachusetts
ZIP/Postal Code
02111
Country
United States
12. IPD Sharing Statement
Learn more about this trial
Effect of Age and Weight Loss on Inflammation and Iron Homeostasis
We'll reach out to this number within 24 hrs